New Hope for IBD Patients
WEDNESDAY, Sept. 29, 2021 (HealthDay News) — A drug previously approved for multiple sclerosis also can treat inflammatory bowel disease in some patients, a new clinical trial reports. The medication, ozanimod (Zeposia), proved effective in helping patients with ulcerative colitis, sending many into full remission, according to results being publishedContinue Reading